Cerebral vascular abnormalities in pediatric patients with sickle cell disease after hematopoietic cell transplant

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 3, 2014, Pages 190-193

  Bodas, Prasad ^a   Rotz, Seth ^b  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

cerebrovascular; MRI; sickle cell; stroke; Transplant

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DISEASE EXACERBATION; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MEDICAL HISTORY; PEDIATRICS; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TRANSIENT ISCHEMIC ATTACK;

ANEMIA, SICKLE CELL; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COHORT STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; PROGNOSIS; REVIEW LITERATURE AS TOPIC;

EID: 84897497005     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000089     Document Type: Article

References (19)

1. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood. 1998;91:288-294
2. DeBaun MR, Armstrong FD, McKinstry RC, et al. Silent cerebral infarcts: A review on a prevalent and progressive cause of neurologic injury in sickle cell anemia. Blood. 2012;119: 4587-4596
3. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med. 1998;339:5-11
4. Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002;140:48-54
5. Hulbert ML, McKinstry RC, Lacey JL, et al. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. Blood. 2011; 117:772-779
6. Pasquini R, Marsh J, Walters M. Meeting Agenda, CIBMTR Working Committee for Non-Malignant Marrow Disorders, 2006;Honolulu, HI, pp3
7. Johnson FL, Look AT, Gockerman J, et al. Bone-marrow transplantation in a patient with sickle-cell anemia. N Engl J Med. 1984;311:780-783
8. Bernaudin F, Socie G, Kuentz M, et al. Long-term results of myeloablative cell transplantation to cure sickle cell disease. Blood. 2007;110:2749-2756
9. Switzer JA, Hess DC, Nichols FT, et al. Pathophysiology and treatment of stroke in sickle-cell disease: Present and future. Lancet Neurol. 2006;5:501-513
10. Merkel KH, Ginsberg PL, Parker JC, et al. Cerebrovascular disease in sickle cell anemia: A clinical, pathological and radiological correlation. Stroke. 1978;9:45-52
11. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360:1226-1237
12. Dobson SR, Holder KR, Nietert PJ, et al. Moyamoya syndrome in childhood sickle cell disease: A predictive vector for recurrent cerebrovascular events. Blood. 2002;99: 3144-3150
13. Walters MC, Rainer S, Patience M, et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report. Blood. 2000;95:1918-1924
14. Vermylen C, Cornu G, Ferster A, et al. Hematopoietic cell transplantation for sickle cell anemia: The first fifty patients transplanted in Belgium. Bone Marrow Transplant. 1998;22: 1-6
15. Woodard P, Helton K, Khan R, et al. Brain parenchymal damage after haematopoetic cell transplantion for severe sickle cell disease. Br J Haematol. 2005;129:550-552
16. Walters MC, Sullivan KM, Bernaudin F, et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood. 1995;85:879-884
17. Bernaudin F, Verlhac S, Arnaud C, et al. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. 2011;117:1130-1140
18. Smith ER, McClain CD, Heeney M, et al. Pial synangiosis in patient with moyamoya syndrome and sickle cell anemia: Perioperative management and surgical outcome. Neurosurg Focus. 2009;26:1-8
19. Ikezaki K. Rational approach to treatment of moyamoya syndrome in childhood. J Child Neurol. 2000;15:350-356